Denali Therapeutics, Inc. (DNLI)

18.30 -0.42 (-2.24%) USD  |  NASDAQ  |  May 01, 16:00
18.30 0.00 (0.00%) After-Hours: 20:00
More

Denali Therapeutics EPS Diluted (Quarterly) : -0.7326 for Dec. 31, 2025

EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for DNLI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Biogen, Inc. 2.153
Neurocrine Biosciences, Inc. 1.482
Protalix Biotherapeutics, Inc. -0.0684
Arcturus Therapeutics Holdings, Inc. -1.034
Agenus, Inc. -0.301

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) -128.55M
Total Expenses (Quarterly) 128.55M
Enterprise Value 2.077B
Earnings Yield -16.22%
Normalized Earnings Yield -16.23